Nathan Ryder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nathan Ryder has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Jason J. Ong
AMelbourne Sexual Health Centre, Bayside Health, Melbourne, Vic, Australia
4 shared publications - Judith Ann Dean
CSchool of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Qld, Australia
3 shared publications Catriona Ooi
JNorthern Sydney Local Health District, Sexual Health Service, St Leonards, NSW, Australia
2 shared publicationsJessica Michaels
BASHM, Sydney, NSW, Australia
2 shared publications- Nicholas A. Medland
Kirby Institute, University of New South Wales, Sydney, Australia
2 shared publications Penny Kenchington
The Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine (ASHM), Sydney, NSW, Australia; and Townsville Hospital and Health Service, Queensland Health, 100 Angus Smith Drive, Douglas, Qld 4814, Australia
2 shared publications
Latest Publications
- 16 June 2026
- Published by CSIRO Publishing in Sexual Health
- Vol. 23 (4)
Priorities to eliminate congenital syphilis in Australia: findings from a national roundtable
Congenital syphilis remains a significant public health threat in Australia, warranting national efforts to reduce syphilis incidence overall, focusing on women of reproductive age. To identify priority actions to eliminate congenital syphilis, ASHM convened a national multidisciplinary roundtable with attendance from organisations, colleges, and bodies across the healthcare sector with a focus on Aboriginal and Torres Strait Islander peoples’ health, sexual and reproductive health, antenatal health, primary care, pathology, and pharmacy, as well as research institutes and community organisations. This position statement outlines the immediate, short-term and long-term actions identified by roundtable participants to eliminate congenital syphilis in Australia.
- 16 June 2026
- Published by CSIRO Publishing in Sexual Health
- Vol. 23 (4)
Priorities to eliminate congenital syphilis in Australia: findings from a national roundtable
Congenital syphilis remains a significant public health threat in Australia, warranting national efforts to reduce syphilis incidence overall, focusing on women of reproductive age. To identify priority actions to eliminate congenital syphilis, ASHM convened a national multidisciplinary roundtable with attendance from organisations, colleges, and bodies across the healthcare sector with a focus on Aboriginal and Torres Strait Islander peoples’ health, sexual and reproductive health, antenatal health, primary care, pathology, and pharmacy, as well as research institutes and community organisations. This position statement outlines the immediate, short-term and long-term actions identified by roundtable participants to eliminate congenital syphilis in Australia.
- Open Access
- 6 May 2025
- Published by CSIRO Publishing in Sexual Health
- Vol. 22 (3)
Do Australian sexual health clinics have the capacity to meet demand? A mixed methods survey of directors of sexual health clinics in Australia
Background: The study describes the capacity of publicly funded sexual health clinics in Australia and explores the challenges they face. Methods: We sent a survey to the directors of publicly funded sexual health clinics across Australia between January and March 2024. The survey asked about how their clinics were managing the current clinical demand. Results: Twenty-seven of 35 directors of sexual health clinics responded. These 27 clinics offered a median of 35 (IQR: 20–60) bookings each day, but only a median of 10 (IQR: 2–15) walk-in consultations for symptomatic patients. The average proportion of days that clinics were able to see all patients who presented with symptoms was 70.1% (95% CI 55.4, 84.9) during summer versus 75.4% (95% CI 62.2, 88.5) during winter. For patients without symptoms, the corresponding proportions were 53.3% (95% CI 37.9, 68.8) during summer versus 57.7% (95% CI 41.7, 73.7) during winter. If these percentages were adjusted for the number of consultations that the clinic provided, then the corresponding numbers for symptomatic individuals was 51.0% for summer and 65.2% for winter, and for asymptomatic individuals it was 48.1% and 49.8%, respectively. The catchment population of the clinics for each consultation they provided ranged from as low as 3696 to a maximum of 5 million (median 521,077). Conclusions: The high proportion of days on which sexual health clinics were not able to see all patients is likely to delay testing and treatment of individuals at high risk of STIs and impede effective STI control.
- 6 May 2025
- Published by CSIRO Publishing in Sexual Health
- Vol. 22 (3)
Open AccessDo Australian sexual health clinics have the capacity to meet demand? A mixed methods survey of directors of sexual health clinics in Australia
Background: The study describes the capacity of publicly funded sexual health clinics in Australia and explores the challenges they face. Methods: We sent a survey to the directors of publicly funded sexual health clinics across Australia between January and March 2024. The survey asked about how their clinics were managing the current clinical demand. Results: Twenty-seven of 35 directors of sexual health clinics responded. These 27 clinics offered a median of 35 (IQR: 20–60) bookings each day, but only a median of 10 (IQR: 2–15) walk-in consultations for symptomatic patients. The average proportion of days that clinics were able to see all patients who presented with symptoms was 70.1% (95% CI 55.4, 84.9) during summer versus 75.4% (95% CI 62.2, 88.5) during winter. For patients without symptoms, the corresponding proportions were 53.3% (95% CI 37.9, 68.8) during summer versus 57.7% (95% CI 41.7, 73.7) during winter. If these percentages were adjusted for the number of consultations that the clinic provided, then the corresponding numbers for symptomatic individuals was 51.0% for summer and 65.2% for winter, and for asymptomatic individuals it was 48.1% and 49.8%, respectively. The catchment population of the clinics for each consultation they provided ranged from as low as 3696 to a maximum of 5 million (median 521,077). Conclusions: The high proportion of days on which sexual health clinics were not able to see all patients is likely to delay testing and treatment of individuals at high risk of STIs and impede effective STI control.
- Open Access
- 29 April 2024
- Published by CSIRO Publishing in Sexual Health
- Vol. 21 (3)
Client and staff perceptions of acceptability of MyCheck: a direct-to-pathology telehealth and e-testing service for comprehensive bloodborne virus and sexually transmissible infection screening
Background: Sydney Sexual Health Centre (SSHC) is the largest sexual health clinic in New South Wales (NSW), servicing clients at high risk of sexually transmissible infections and bloodborne viruses. SSHC piloted a direct-to-pathology pathway that facilitated bloodborne virus/sexually transmissible infection testing at one of the ~500 participating pathology collection centres located across NSW. This qualitative study sought to understand SSHC client and provider perspectives of acceptability of the MyCheck intervention. Methods: Semi-structured in-depth interviews were conducted with 11 clients who underwent testing via the MyCheck pathway and eight staff members involved in implementing MyCheck. The seven components of Sekhon’s Theoretical Framework of Acceptability informed this analysis. Results: Participants broadly conveyed ‘affective attitude’ toward the MyCheck pathway. The telehealth intervention reduced client ‘burden’ and ‘opportunity cost’ through enabling greater testing convenience at a location suitable to them and provided timely results. Issues of ‘ethicality’ were raised by clients and staff as pathology centre staff were, on a few occasions, regarded as being judgmental of SSHC clients. ‘Intervention coherence’ issues were largely attributed to pathology centre personnel being unfamiliar with the intervention, with billing issues being a recurrent concern. Participants perceived MyCheck as an ‘effective’ testing pathway. SSHC staff were able to offer the intervention with ease through seamless IT integration (‘self-efficacy’). Conclusion: The MyCheck intervention was perceived by both SSHC clients and staff as an acceptable bloodborne virus/sexually transmissible infection testing pathway. However, further work is required to address stigma experienced by some clients when attending pathology collection centres.
- 29 April 2024
- Published by CSIRO Publishing in Sexual Health
- Vol. 21 (3)
Open AccessClient and staff perceptions of acceptability of MyCheck: a direct-to-pathology telehealth and e-testing service for comprehensive bloodborne virus and sexually transmissible infection screening
Background: Sydney Sexual Health Centre (SSHC) is the largest sexual health clinic in New South Wales (NSW), servicing clients at high risk of sexually transmissible infections and bloodborne viruses. SSHC piloted a direct-to-pathology pathway that facilitated bloodborne virus/sexually transmissible infection testing at one of the ~500 participating pathology collection centres located across NSW. This qualitative study sought to understand SSHC client and provider perspectives of acceptability of the MyCheck intervention. Methods: Semi-structured in-depth interviews were conducted with 11 clients who underwent testing via the MyCheck pathway and eight staff members involved in implementing MyCheck. The seven components of Sekhon’s Theoretical Framework of Acceptability informed this analysis. Results: Participants broadly conveyed ‘affective attitude’ toward the MyCheck pathway. The telehealth intervention reduced client ‘burden’ and ‘opportunity cost’ through enabling greater testing convenience at a location suitable to them and provided timely results. Issues of ‘ethicality’ were raised by clients and staff as pathology centre staff were, on a few occasions, regarded as being judgmental of SSHC clients. ‘Intervention coherence’ issues were largely attributed to pathology centre personnel being unfamiliar with the intervention, with billing issues being a recurrent concern. Participants perceived MyCheck as an ‘effective’ testing pathway. SSHC staff were able to offer the intervention with ease through seamless IT integration (‘self-efficacy’). Conclusion: The MyCheck intervention was perceived by both SSHC clients and staff as an acceptable bloodborne virus/sexually transmissible infection testing pathway. However, further work is required to address stigma experienced by some clients when attending pathology collection centres.
- Open Access
- 17 March 2023
- Published by CSIRO Publishing in Sexual Health
- Vol. 20 (2) , 99-104
Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand – the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)
Recent studies have provided evidence for the effectiveness of using doxycycline (Doxy-PEP) to prevent bacterial sexually transmissible infections (STI), namely chlamydia, gonorrhoea, and syphilis, among gay, bisexual, and other men who have sex with men who have experienced multiple STIs. However, there remain several unanswered questions around potential adverse outcomes from Doxy-PEP, including the possibility of inducing antimicrobial resistance in STIs and other organisms, and the possibility of disrupting the microbiome of people who choose to use Doxy-PEP. This interim position statement from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine aims to outline the current evidence for Doxy-PEP, and to highlight potential adverse outcomes, to enable clinicians to conduct evidence-based conversations with patients in Australia and Aotearoa New Zealand who intend to use Doxy-PEP.
- 17 March 2023
- Published by CSIRO Publishing in Sexual Health
- Vol. 20 (2) , 99-104
Open AccessInterim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand – the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)
Recent studies have provided evidence for the effectiveness of using doxycycline (Doxy-PEP) to prevent bacterial sexually transmissible infections (STI), namely chlamydia, gonorrhoea, and syphilis, among gay, bisexual, and other men who have sex with men who have experienced multiple STIs. However, there remain several unanswered questions around potential adverse outcomes from Doxy-PEP, including the possibility of inducing antimicrobial resistance in STIs and other organisms, and the possibility of disrupting the microbiome of people who choose to use Doxy-PEP. This interim position statement from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine aims to outline the current evidence for Doxy-PEP, and to highlight potential adverse outcomes, to enable clinicians to conduct evidence-based conversations with patients in Australia and Aotearoa New Zealand who intend to use Doxy-PEP.
- Open Access
- 24 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0280339
Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study
Background: Tenofovir disoproxil fumarate (TDF) is associated with adverse renal outcomes when prescribed for HIV infection. There are few data concerning real-world renal outcomes amongst patients prescribed TDF for pre-exposure prophylaxis (PrEP).Methods and findings: Data were extracted from 52 sexual health clinics across Australia from 2009–2019. All patients prescribed TDF-containing antiretroviral therapy and PrEP were included. Rates of renal impairment (a fall in eGFR to 2) were calculated for people living with HIV (PLWHIV) prescribed TDF and HIV negative PrEP-users. Risk factors were assessed using Cox-proportional hazards models. Sensitivity analysis of risk using 1:1 propensity-score matching to adjust for potential imbalance in HIV and PrEP cohorts was conducted. 5,973 patients on PrEP and 1,973 PLWHIV were included. There were 39 (0.7%) instances of renal impairment in the PrEP group and 81 (4.1%) in the PLWHIV cohort (hazard ratio [HR]:0.35 95% confidence interval [CI]: 0.22–0.56). Rates of renal impairment were 4.01/1000 person-years (95%CI:2.93–5.48) in the PrEP cohort and 16.18/1000 person-years (95%CI:13.01–20.11) in the PLWHIV cohort (p<0.001). Predictors of renal impairment were: older age (40–49 years (HR:5.09 95%CI: 2.12–12.17) and 50–82 years (HR:13.69 95%CI: 5.92–31.67) (compared with 30–39 years) and baseline eGFR<90ml/min (HR:61.19 95%CI: 19.27–194.30). After adjusting for age and baseline eGFR the rate of renal impairment remained lower in the PrEP cohort (aHR:0.62 95%CI: 0.40–0.94, p = 0.023). In propensity-matched analysis using 1,622 patients per cohort the risk of renal impairment remained higher in the PLWHIV cohort (log-rank p = 0.001).Conclusion: Patients prescribed TDF-based PrEP had lower rates of renal impairment than patients prescribed TDF for HIV infection. In propensity analysis, after matching for some risk factors, rates of renal impairment remained higher amongst patients with HIV.
- 24 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0280339
Open AccessRenal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study
Background: Tenofovir disoproxil fumarate (TDF) is associated with adverse renal outcomes when prescribed for HIV infection. There are few data concerning real-world renal outcomes amongst patients prescribed TDF for pre-exposure prophylaxis (PrEP).Methods and findings: Data were extracted from 52 sexual health clinics across Australia from 2009–2019. All patients prescribed TDF-containing antiretroviral therapy and PrEP were included. Rates of renal impairment (a fall in eGFR to 2) were calculated for people living with HIV (PLWHIV) prescribed TDF and HIV negative PrEP-users. Risk factors were assessed using Cox-proportional hazards models. Sensitivity analysis of risk using 1:1 propensity-score matching to adjust for potential imbalance in HIV and PrEP cohorts was conducted. 5,973 patients on PrEP and 1,973 PLWHIV were included. There were 39 (0.7%) instances of renal impairment in the PrEP group and 81 (4.1%) in the PLWHIV cohort (hazard ratio [HR]:0.35 95% confidence interval [CI]: 0.22–0.56). Rates of renal impairment were 4.01/1000 person-years (95%CI:2.93–5.48) in the PrEP cohort and 16.18/1000 person-years (95%CI:13.01–20.11) in the PLWHIV cohort (p<0.001). Predictors of renal impairment were: older age (40–49 years (HR:5.09 95%CI: 2.12–12.17) and 50–82 years (HR:13.69 95%CI: 5.92–31.67) (compared with 30–39 years) and baseline eGFR<90ml/min (HR:61.19 95%CI: 19.27–194.30). After adjusting for age and baseline eGFR the rate of renal impairment remained lower in the PrEP cohort (aHR:0.62 95%CI: 0.40–0.94, p = 0.023). In propensity-matched analysis using 1,622 patients per cohort the risk of renal impairment remained higher in the PLWHIV cohort (log-rank p = 0.001).Conclusion: Patients prescribed TDF-based PrEP had lower rates of renal impairment than patients prescribed TDF for HIV infection. In propensity analysis, after matching for some risk factors, rates of renal impairment remained higher amongst patients with HIV.
- Open Access
- 11 November 2022
- Published by CSIRO Publishing in Sexual Health
- Vol. 20 (1) , 1-8
Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update
The ‘Australian Sexually Transmitted Infection (STI) Management Guidelines For Use In Primary Care’ (www.sti.guidelines.org.au) provide evidence-based, up-to-date guidance targeted at use in primary care settings. A major review of the guidelines was undertaken in 2020–22. All content was reviewed and updated by a multi-disciplinary group of clinical and non-clinical experts, and assessed for appropriateness of recommendations for key affected populations and organisational and jurisdictional suitability. The guidelines are divided into six main sections: (1) standard asymptomatic check-up; (2) sexual history; (3) contact tracing; (4) STIs and infections associated with sex; (5) STI syndromes; and (6) populations and situations. This paper highlights important aspects of the guidelines and provides the rationale for significant changes made during this major review process.
- 11 November 2022
- Published by CSIRO Publishing in Sexual Health
- Vol. 20 (1) , 1-8
Open AccessAustralian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update
The ‘Australian Sexually Transmitted Infection (STI) Management Guidelines For Use In Primary Care’ (www.sti.guidelines.org.au) provide evidence-based, up-to-date guidance targeted at use in primary care settings. A major review of the guidelines was undertaken in 2020–22. All content was reviewed and updated by a multi-disciplinary group of clinical and non-clinical experts, and assessed for appropriateness of recommendations for key affected populations and organisational and jurisdictional suitability. The guidelines are divided into six main sections: (1) standard asymptomatic check-up; (2) sexual history; (3) contact tracing; (4) STIs and infections associated with sex; (5) STI syndromes; and (6) populations and situations. This paper highlights important aspects of the guidelines and provides the rationale for significant changes made during this major review process.
- Open Access
- 1 September 2015
- Published by Australian Centre for Disease Control in Communicable Diseases Intelligence
- Vol. 39 (3) , 323-328
Notification and management of congenital syphilis in the Northern Territory 2009 to 2014
Objective: To determine whether cases of congenital syphilis in the Northern Territory between 2009 and 2014 were correctly notified based on probable or confirmed case criteria stipulated by the Communicable Diseases Network Australia (CDNA).Methods: Pregnant women with positive syphilis serology defined as reactive treponemal test and rapid plasma reagin titre ≥1:8 were identified from the Northern Territory Syphilis Register Information System. Risk classification was performed based on local guidelines, and CDNA criteria for probable/confirmed cases of congenital syphilis were applied to determine whether cases were appropriately notified.Results: Thirty-four cases of positive maternal syphilis serology in pregnancy were identified from 31 women; all were Indigenous. Twenty-one cases fulfilled criteria for probable congenital syphilis; 1 case was formally notified to the Centre for Disease Control. Twenty cases (95%) fulfilling CDNA criteria for probable congenital syphilis were not notified over the study period.Conclusions: Application of standard case definitions significantly increases the rate of congenital syphilis cases in the Northern Territory. Improved education regarding CDNA criteria for notification of congenital syphilis is necessary for clinicians and public health staff. Emerging evidence has supported the recent simplification of CDNA criteria for notification of congenital syphilis, effective 1 July 2015. Commun Dis Intell 2015;39(3):E323–E328.
- 1 September 2015
- Published by Australian Centre for Disease Control in Communicable Diseases Intelligence
- Vol. 39 (3) , 323-328
Open AccessNotification and management of congenital syphilis in the Northern Territory 2009 to 2014
Objective: To determine whether cases of congenital syphilis in the Northern Territory between 2009 and 2014 were correctly notified based on probable or confirmed case criteria stipulated by the Communicable Diseases Network Australia (CDNA).Methods: Pregnant women with positive syphilis serology defined as reactive treponemal test and rapid plasma reagin titre ≥1:8 were identified from the Northern Territory Syphilis Register Information System. Risk classification was performed based on local guidelines, and CDNA criteria for probable/confirmed cases of congenital syphilis were applied to determine whether cases were appropriately notified.Results: Thirty-four cases of positive maternal syphilis serology in pregnancy were identified from 31 women; all were Indigenous. Twenty-one cases fulfilled criteria for probable congenital syphilis; 1 case was formally notified to the Centre for Disease Control. Twenty cases (95%) fulfilling CDNA criteria for probable congenital syphilis were not notified over the study period.Conclusions: Application of standard case definitions significantly increases the rate of congenital syphilis cases in the Northern Territory. Improved education regarding CDNA criteria for notification of congenital syphilis is necessary for clinicians and public health staff. Emerging evidence has supported the recent simplification of CDNA criteria for notification of congenital syphilis, effective 1 July 2015. Commun Dis Intell 2015;39(3):E323–E328.
- Open Access
- 25 February 2015
- Published by Elsevier in Australian and New Zealand Journal of Public Health
- Vol. 39 (3) , 293-294
Effectiveness of using Grindr to increase syphilis testing among men who have sex with men in Darwin, Australia
- 25 February 2015
- Published by Elsevier in Australian and New Zealand Journal of Public Health
- Vol. 39 (3) , 293-294
Open AccessEffectiveness of using Grindr to increase syphilis testing among men who have sex with men in Darwin, Australia